Exploring Development of an In Vitro Bone Marrow Strategy to Recapitulate & Support ADC Toxicity Assessment
- Delving into the development of a suite of bone marrow in vitro models to utilise in preclinical ADC haematotoxicity assessment
- Evaluating in vitro model capability to replicate clinical ADC toxicities and support drug development
- Understanding limitations of ADC in vitro models and exploring future directions to overcome them